Jacobs Bruce N.
5 of 10 shown
The 5 most recent of 10 visible filings, newest first.
- Kymera Therapeutics, Inc. Chief financial officer61,378 sharesOption exercise
- Kymera Therapeutics, Inc. Chief financial officer$376,649Open-market sale
- Kymera Therapeutics, Inc. Chief financial officer$719,862Open-market sale
- Kymera Therapeutics, Inc. Chief financial officer$923,178Open-market sale
- Kymera Therapeutics, Inc. Chief financial officer$5,896,288Open-market sale